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Abstract: Acinetobacter baumannii is an opportunistic pathogen that presents a serious clinical challenge
due to its increasing resistance to all available antibiotics. Phage therapy has been introduced
recently to treat antibiotic-incurable A. baumannii infections. In search for new A. baumannii specific
bacteriophages, 20 clinical A. baumannii strains were used in two pools in an attempt to enrich phages
from sewage. The enrichment resulted in induction of resident prophage(s) and three temperate
bacteriophages, named vB_AbaS_fEg-Aba01, vB_AbaS_fLi-Aba02 and vB_AbaS_fLi-Aba03, all able
to infect only one strain (#6597) of the 20 clinical strains, were isolated. Morphological characteristics
obtained by transmission electron microscopy together with the genomic information revealed that
the phages belong to the family Siphoviridae. The ca. 35 kb genomic sequences of the phages were
>99% identical to each other. The linear ds DNA genomes of the phages contained 10 nt cohesive end
termini, 52–54 predicted genes, an attP site and one tRNA gene each. A database search revealed an
>99% identical prophage in the genome of A. baumannii strain AbPK1 (acc. no. CP024576.1). Over
99% identical prophages were also identified from two of the original 20 clinical strains (#5707 and
#5920) and both were shown to be spontaneously inducible, thus very likely being the origins of
the isolated phages. The phage vB_AbaS_fEg-Aba01 was also able to lysogenize the susceptible
strain #6597 demonstrating that it was fully functional. The phages showed a very narrow host range
infecting only two A. baumannii strains. In conclusion, we have isolated and characterized three novel
temperate Siphoviridae phages that infect A. baumannii.
Keywords: Acinetobacter baumannii; temperate; bacteriophage; Siphoviridae; genome; att site; prophage;
cohesive ends
1. Introduction
Acinetobacter baumannii is a Gram-negative non-fermenting aerobic coccobacillus that plays a
significant role in infecting patients admitted to hospitals [1,2]. A. baumannii is a relatively newly
emerged pathogen, notorious for its role as prominent causative agents of nosocomial wound as well as
community-acquired infections [3]. A. baumannii has become a challenge for modern medicine due to
being one of the most important multiple-drug resistant (MDR) nosocomial pathogens. The antibiotic
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resistance mechanisms of A. baumannii include enzymatic inactivation of the drugs, modification of the
drug target site, and active efflux or decreased influx of drugs [4]. Thus, the control and therapeutic
management of A. baumannii has becomes a pressing concern [4–6]. Pan-resistant strains, resistant to
all available antibiotics, have been encountered [7]. Carbapenems (imipenem and meropenem) and
colistin (polymyxin B) antibiotics are the last resort for treatment of Gram-negative bacterial infections;
but resistant strains have been widely reported in clinical settings [8,9]. Due to this threat, phage
therapy has been considered, and already used, as an alternative treatment to manage infections caused
by MDR pathogens [10,11], also recently in animals [12,13] and humans [14,15] against infections
caused by MDR A. baumannii.
Bacteriophages (phages) are viruses that infect and reproduce in bacteria. The use of phages as
therapeutic agents was initiated after their discovery by Frederick Twort in 1915 and Felix d’Herelle in
1917, where after, phages were used to treat a variety of bacterial infections all over the world [16,17].
Phages are highly host-specific [18], and their taxonomy is based on their morphology as well as on
their nucleic acid [19,20]. Phages fall into two main classes.
• Virulent (lytic) phages follow the lytic infection cycle in which the phage overtakes the bacterial
cell, reproduces itself at the expense of the host, and finally lyses and kills the host cell to release
its progeny to the environment. This ability is the cornerstone of phage therapy [21].
• Temperate phages may enter the lysogenic cycle in which the phage genome integrates into the
host genome using the activity of phage-encoded integrase, and the resulting bacteria are called
lysogens. The integrated phage is called a prophage, it replicates as part of the host genome,
and stays dormant for extended periods of time, due to the activity of a specific repressor that
prevents the expression of the phage lytic cycle genes. The prophage may become induced and
turn on the lytic cycle genes when the lysogen encounters adverse environmental conditions.
The stress triggers the SOS (emergency) response, and the overexpression of proteases causes the
degradation of the phage repressor thereby turning on the lytic cycle. The archetype of temperate
phages is phage lambda [22].
Temperate phages which enter lysogeny maintain a long-term association with their host bacteria
if they produce a mutually beneficial interaction that support efficient reproduction of both phages
and bacteria [23]. The phages integration into the host genome is a crucial step in the lysogenic
cycle and is mediated by the integrase protein, a DNA recombinase encoded by bacteriophages, at a
distinct bacterial genome attachment site (attB), which is identical to an attachment site (attP) of the
prophage genome [23]. Prophages do not integrate randomly into the host genomes. For example,
prophages encoding a tyrosine integrase are usually integrated next to their host tyrosine tRNA gene
and the palindromic structures of those temperate phages allow their integration within the bacterial
genome [24].
Temperate phages are natural vectors for gene transmission among bacteria owing to their
ability to integrate as prophages, and, consequently, affect the fitness and phenotype of the produced
lysogen [25]. Several virulence factor or toxin encoding genes of pathogenic bacteria have been
associated with prophages, indicating that temperate phages may play a significant role in increasing
the host pathogenicity, on the other hand, a virulence-attenuating role is not often reported for
temperate phages [26,27].
Whole genome sequences of several A. baumannii strains have revealed that they are polylysogenic,
i.e., they harbor multiple integrated prophages [28]. Some prophages provide their host bacteria
beneficial traits that increase the host fitness [29], some encode virulence factors including toxins
that may benefit host pathogenesis [30] or antibiotic tolerance [31]. Prophages also protect the host
bacteria against infection by other phages [32]. Resistance and other bacterial virulence elements
are contained on highly mobile pieces of DNA that can easily spread to other bacteria. Prophages
are one of the facilitators of this form of horizontal gene transfer, and have been discovered very
often in bacterial genomes, offering advantageous features to the host. Prophages are claimed to be
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one of the major causes behind the evolution of A. baumannii pathogenicity [33]. Also remarkably,
A. baumannii prophages encode for multiple putative virulence factors that may be implicated in the
bacterium’s capacity to colonize host niches, prevent the host immune system, survive in unfavorable
environments, and tolerate antibiotics. Overall the results point towards a significant contribution
of prophages for the spreading and evolution of pathogenicity in A. baumannii, and highlight their
clinical relevance [33].
Some phage therapy trials have failed in the past apparently due to lack of knowledge on phage
biology and due to use of uncharacterized phages [34]. Therefore, there is still room for more studies to
provide greater understanding of phage biology to avoid failures in phage therapy [35]. In our search
for new A. baumannii specific bacteriophages we isolated three temperate bacteriophages with a very
narrow host range belonging to the family Siphoviridae. The ca. 35 kb genomes were >99% identical to
each other, contained 10 nt cohesive end termini, 52–54 predicted genes, an attP site and one tRNA
gene each. We also present data that the phages were induced from two of the clinical strains used for
the search and that one of the phages was able to lysogenize a susceptible strain demonstrating that it
was fully functional.
2. Materials and Methods
2.1. Bacterial Strains, Media and Growth Conditions
The clinical A. baumannii and other bacterial strains used in this study (Table S1) originated from
diverse patient samples (wound, tissue, sputum, broncho-alveolar lavage, trachea, pleural fluid, urine,
bile, blood, rectum and drainage and intravenous catheters) isolated at Department of Bacteriology,
University of Helsinki and Helsinki University Central Hospital (HUSLAB), Helsinki, Finland. The
A. baumannii strain DSM 106838 (storage number #6597, Table S1) was received from DSMZ, the
German Collection of Microorganisms and Cell Cultures GmbH. The bacteria were grown with shaking
at 220 rpm in lysogeny broth (LB) [36] medium at 37 ◦C overnight (16–24 h). Luria agar (LA) plates
contained LB supplemented with 1.5% agar and soft agar contained LB supplemented 0.4% agar. All
strains were stored in tryptic soy broth containing 20% glycerol at −80 ◦C. The strains are identified in
the text by their storage numbers (Table S1).
2.2. Bacteriophage Isolation and Propagation
Enrichments of Acinetobacter specific bacteriophages were carried out as described [37] with some
modifications. Twenty clinical A. baumannii strains were grown separately at 37 ◦C for 16 h and
100 µL of each culture was combined into two sets of parallel pools with 10 strains each. One mL of
a sterile-filtered (0.45 µm) sewage filtrates was mixed with each pair of pools to which 9 mL of LB
was added. These pooled enrichment cultures were incubated overnight on a rocking platform at
37 ◦C to allow enrichment of any Acinetobacter-specific phages present. To each 3 mL portion of the
enrichment cultures 0.2 mL of chloroform was added to kill and lyse the bacteria, and the mixture was
shaken for 20 min at room temperature (RT). The chloroform-treated lysates were then clarified by
centrifugation at 5000 rpm for 10 min at 4 ◦C, and the supernatants filtered through 0.45 µm filters
(Minisart® Sartorius, Göttingen, Germany) to remove bacterial cells. The obtained lysates were then
stored at 4 ◦C for bacteriophage isolation.
2.3. Bacteriophage Titration by Droplet and Double-Agar Overlay Methods
One hundred µL of indicator bacteria (OD600~1.0) was mixed into 3 mL of molten soft agar
(adjusted to 50 ◦C) and immediately poured on warm LA plates. The soft agar was allowed to solidify
at RT for 20 min. The enrichment lysates or phage suspensions to be tested were serially 10-fold diluted
in SM buffer (50 mM Tris-HCL, 100 mM NaCl, 8 mM MgSO4·7H2O, 0.01% gelatin, pH 7.5). Five µL
droplets of the undiluted and diluted suspensions were pipetted on the solidified soft agar plates that
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were incubated overnight at 37 ◦C. The plates were observed for the presence of bacterial lysis under
the droplets to indicate the presence of phages [38].
For double-agar overlay titration method appropriate dilutions of the phage suspension, estimated
based on the droplet titration results, were prepared to contain 50–500 plaque forming units (PFU) per
50 µL. The 50 µL phage aliquots and 100 µL of indicator bacteria (OD600~1.0) were pipetted into 3 mL
of 50 ◦C-adjusted soft agar, carefully mixed and poured on LA plates. After overnight incubation the
individual plaques were enumerated and the original phage titers (PFU/mL), calculated based on the
plaque numbers and the dilution factors [18,39].
2.4. Plaque Purification
Individual plaques on double-agar overlay plates were used for plaque purification of individual
phages. A well-isolated single plaque was punched out using a sterile Pasteur pipette and transferred
to an Eppendorf tube containing 500 µL of SM buffer and 50 µL of chloroform. The tube was shaken for
20 min at RT, centrifuged at 11,000× g for 10 min at 4 ◦C, and 300 µL of the water phase was transferred
to a new Eppendorf tube that was kept cap open in a laminar-flow safety cabinet to evaporate the
residual chloroform. The phage concentration was titrated, and single plaque purification was repeated
from new double agar overlay plates at least five times to ensure purity of each phage [40].
2.5. Preparation of Phage Stocks
Phage stocks were prepared from semiconfluent soft agar plates prepared using appropriately
diluted purified phage solutions. Plates were incubated overnight, and 3 mL of SM buffer was added
on the semiconfluent lawn of plaques and incubated at RT for 30 min on a rocking platform. The soft
agar and the buffer were collected into a 15-mL polypropylene (PP) tube, and the remaining soft agar
was recovered by repeating the procedure. Two hundred µL chloroform was added to every 3 mL of
the combined soft agar samples, the tubes were mixed for 15–20 min at RT, and centrifuged at 5000× g
for 10 min at 4 ◦C. The supernatant was filtered through a 0.45-µm filter (Minisart® Sartorius) into a
sterile 15-mL PP tube, and 40% sucrose was added to final concentration of 8%. The obtained stocks
were titrated and stored at 4 ◦C [41,42].
2.6. Phage Purification from Liquid Lysates
Large scale lysates of phages were prepared in 500 mL cultures. A. baumannii strain #6597 (Table
S1) served as a host strain for the propagation of phages. Phages were precipitated from the lysate
according to [43] with some modifications. DNase I and RNase were added, each to final concentration
of 1 µg mL−1, to the lysate that was incubated for 30 min at RT. Solid NaCl (29.2 g) was dissolved into
the lysate (1 M final concentration) that was incubated on ice for 1 h prior centrifugation at 11,000× g for
10 min at 4 ◦C to remove bacterial debris. PEG-8000 was slowly stirred into the supernatant to a final
concentration of 10% at RT after which the solution was incubated at least 1 h at 4 ◦C to precipitate the
phage particles. The precipitated phages were pelleted by centrifugation at 11,000× g for 10 minutes at
4 ◦C. After carefully removing all liquid from the centrifuge bottles, the phage pellet was resuspended
gently into 8 mL SM buffer. To remove residual PEG, the suspension was extracted thrice with an equal
volume of chloroform followed by centrifugation at 3000× g for 15 min at 4 ◦C. The phage preparations
were further purified by discontinuous glycerol density gradient ultracentrifugation through 5% and
40% glycerol layers in TM buffer using the Beckman BSW55Ti rotor at 40,000 rpm at 4 ◦C for 3 h [44].
The phage pellet was resuspended in SM buffer containing 8% sucrose.
2.7. Transmission Electron Microscopy
A 3 µL drop of purified high-titer (1010–1013 PFU/mL) phage in 0.1 M ammonium acetate, pH 7.0,
concentrated using a 105 Da cut-off Vivaspin ultrafiltration (Minisart® Sartorius), was deposited on
carbon-coated 400 mesh copper grid and allowed to adsorb for 1 min, followed by 2% uranyl acetate
for 30 s [45]. Samples were examined with a JEOL JEM-1400 transmission electron microscope JEOL
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Ltd., Tokyo, Japan) under 80 kV at the electron microscopy unit (Institute of Biotechnology, University
of Helsinki, Helsinki, Finland). Pictures were taken using Gatan Orius SC 1000B bottom-mounted
charged coupled device (CCD)-camera (Gatan Inc., Pleasanton, CA, USA). The dimensions of at least
10 phage particles measured to calculate the average and standard error values.
2.8. Phage Adsorption Assay
Adsorption is the first step of phage infection of host bacteria. Approximately 3 × 105 PFU in
100 µL was mixed with a 500 µL of A. baumannii strain #6597 grown to OD600 ~ 1–1.2 in LB, and to a
control tube with 500 µL sterile LB. The tubes were incubated at 37 ◦C and at different time points (1, 5,
10, 15, 20, 25, and 30 min) the tubes were centrifuged at 16,000× g for 3 min and the supernatants placed
immediately on ice until titrated for non-adsorbed phages. The phage titers were compared to that of
the control supernatant set as 100%. Each assay was performed in duplicate and repeated for 3 times.
2.9. Phage Host Range Determination
The host specificity of the phages was determined by the droplet titration method (described
above) on 91 strains (Table S1) including 21 A. baumannii, 18 A. pittii, one A. calcoaceticus, one A. junii,
three A. lwoffii, three A. nosocomialis, two A. radioresistens, three A. ursingii, one Acinetobacter sp, 24
Escherichia coli, 10 Staphylococcus aureus, two Pseudomonas aeruginosa, one Yersinia pseudotuberculosis and
one Klebsiella pneumoniae strain(s). Positive droplet test results were confirmed by the double-layer
method using appropriately diluted phage preparations.
2.10. Phage and Bacterial DNA Extraction
Phage DNA isolation was performed from 1010–1013 PFU/mL phage preparations using the
phenol-chloroform extraction method [43] with some modifications. Briefly, to 400 µL of the phage
suspension 1.3 µL DNase I (1 U/µL, Promega, Madison, WI, USA) and 4 µL RNase A (1 mg/mL) were
added and the mix was incubated 30 min at 37 ◦C to degrade bacterial DNA and RNA. Then, 16
µL of 0.5 M EDTA, 1.2 µL of proteinase K (20 mg/mL), and 20 µL 10% SDS were added to the tube
that was incubated at 56 ◦C for at least 1 h. The cooled suspension was extracted sequentially with
a volume of phenol, phenol/chloroform (1/1) and chloroform, each time mixing the tube gently for
15 min, followed by 5 min centrifugation at 16,000× g. The nucleic acid was precipitated from the
final aqueous phase by adding 0.1 volumes of 3 M sodium acetate pH 5.2, and 2 volumes of absolute
ethanol. The tube was mixed manually for 2–3 min until the precipitated DNA thread became visible,
and could be transferred using a 1 µL inoculation loop into a tube containing 1 mL 70% EtOH. After
10 min centrifugation at RT, the supernatant was carefully removed and the pellet was air dried and
dissolved overnight into 50–100 µL of TE buffer (10 mM Tris-HCL, 1 mM EDTA, pH 8.0). In the case
that the DNA thread failed to form, the DNA was pelleted by centrifugation, and washed with 1 mL of
70% EtOH as above. The isolation and purification of the genomic DNA from bacterial strains was
accomplished using JetFlex Genomic DNA Purification Kit (Thermo Fisher Scientific, Waltham, MA,
USA) following the manufacturer’s instructions. The quality and quantity of the DNA was estimated
using the NanoDrop spectrophotometer (ND-1000, Wilmington, DE, USA) and/or the Qubit machine
(Invitrogen Qubit 2.0 Fluorometer, CA, USA) applying the QubitTM dsDNA BR Assay Kit (Thermo
Fisher Scientific), followed by visualization by agarose gel electrophoresis [40].
2.11. Genome Sequencing, Assembly and Bioinformatics Based on Sequence Analysis
The genomic DNA of the phages and of the bacterial strains was sequenced at Eurofins Genomics
(https://www.eurofinsgenomics.eu/) using Illumina HiSeq with 150-bp paired-end reads. The DNA
was fragmented using sonication into 300–600 bp fragments that were then processed to generate DNA
libraries. The obtained sequence reads were assembled de novo using the A5-miseq pipeline [46].
The read coverage of the resulting contigs were checked with the Artemis software [47,48] and the
contaminating bacterial genomic sequences identified by their >100-fold lower read coverages (the read
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coverage of the phage contig was >10,000) and BLASTN searches. To verify the fidelity of the assemblies,
the reads were mapped back to the de novo assembled contigs using the Geneious (Biomatters Ltd.,
Auckland, New Zealand) prime R10 software version 2019.0.4. tools [49]. Preliminary annotation of the
phage genomes were carried out using rapid annotation subsystems technology (RAST) [50] that was
manually checked and revised with the Artemis software [47,48]. The PhageTerm program was used to
identify the termini of the phage genomes [51]. The identities and functions of the predicted genes and
gene products were analyzed using the BLASTP (https://blast.ncbi.nlm.nih.gov/Blast) and HHpred [52]
servers. Different EMBOSS sequence analysis tools were used through the Chipster platform [53]
at the Centers for Scientific Computing (https://www.csc.fi/). The multiple sequence alignment
program MAFFT was used to compare phage genome sequences [54]. The phylogentic trees were
constructed using the Molecular Evolutionary Genetic Analysis Software, Version X (MEGA X), where
the neighbor-joining statistical tree analysis method was used. The number of bootstrap replications
was set at 1000. The Poisson substitution model was used within the MEGA X software [55]. The phage
and prophage whole genome sequence phylogenetic tree was constructed using the VIrus Classification
and Tree building Online Resource (VICTOR) [56]. The A. baumannii strain multilocus sequence types
(MLST) were determined using the PubMLST web service (https://pubmlst.org/abaumannii/) and the
O- and K-serotypes using the Kaptive service [57].
2.12. PCR and Sanger Sequencing
The PCR primers (Table S2) were designed using the EMBOSS Eprimer3 tool in Chipster [53],
and commercially synthetized at Metabion International AG (Steinkirchen, Germany). The PCRs were
performed in 0.2 mL thin walled PCR tubes (4titude® Ltd, Wotton, UK), in a total volume of 25 µL
containing 1 µL of DNA template, 0.2 µM of each primer (Table S2), 200 µM of dNTP mix (Thermo
Fisher Scientific), 2.5 µL of 10× Standard Taq Reaction Buffer and 1.25 U of Taq DNA Polymerase
(Thermo Fisher Scientific). The PCR cycling included an initial denaturation at 95 ◦C for 3 min,
followed by 34 cycles each consisting of denaturation at 95 ◦C for 30 s, 30 s at annealing temperature,
and extension for 30 s at 72 ◦C. This was followed by a final extension step at 72 ◦C for 5 min after
which PCR products were kept on hold, at 4 ◦C, until further processing. The annealing temperatures
were calculated using the net service at https://www.thermofisher.com/. The PCR products were
analyzed using 1% agarose gel electrophoresis and cleaned using the Nucleospin Gel extraction and
PCR clean-up kit (Macherey-Nagel GmbH, Düren, Germany). The purified PCR fragments were
sequenced with appropriate sequencing primers using the Sanger sequencing service at the Institute
for Molecular Medicine Finland (https://www.fimm.fi/en/services/technology-centre/sequencing).
2.13. Restriction Endonuclease Analysis
Restriction digestions were carried out using the restriction enzymes EcoRI, HincII, NsiI, PstI,
SalI, ScaI, SexAI, and SpeI (Thermo Fischer Scientific). These enzymes gave several well separated
bands when in silico digested by the NEBcutter (http://nc2.neb.com/NEBcutter2/). The digestions were
carried out in a final volume of 10 µL, containing DNA (ca. 300 ng), 0.5 µL of enzyme and 1 µL of Fast
digest green buffer (10×, Thermo Fisher Scientific). After 2–16 h incubation at 37 ◦C the restriction
fragments along with undigested DNA and GeneRuler 1 kb DNA Ladder (Thermo Fisher Scientific)
were loaded on 1% (w/v) agarose gel including 0.005% (w/v) Midori green. After the electrophoresis the
fragments were visualized using UV transillumination and images recorded using the BioRad GelDoc
XR+ imaging system.
2.14. Lysogenization Experiment
To test the ability of the phages to form lysogens, phage resistant colonies were isolated and
prophage inductions were performed as described [58] with some modifications. The prophage-free
A. baumannii strain #6597 was used as a host for the lysogenization test [59]. Bacterial suspension was
spread on LA plate, allowed to dry for a while, and 10 µL drops of phage stock were pipetted on the
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bacterial lawn. After 48 h incubation at 37 ◦C, ten surviving colonies were selected randomly from
within the lysis zones, further tested for phage resistance. To confirm the integration of the phage
genome, bacterial DNA isolated from the confirmed phage-resistant strains was used as template in
phage-specific PCRs as described above.
2.15. Prophage Induction Experiments
Spontaneous prophage induction from A. baumannii strains #5707 and #5920 was carried out by
inoculating a single colony from each strain separately in 5 mL of LB, incubating overnight at 37 ◦C.
The culture was split into two and to one portion of the cultures, 0.2 mL of chloroform was added to
kill and lyse the bacteria, and the mixture was shaken for 20 min at RT. The chloroform-treated lysates
and non-treated cultures were then clarified by centrifugation at 5000 rpm for 10 min at 4 ◦C, and
the supernatants filtered through 0.45 µm filters (Minisart® Sartorius) to remove bacterial cells. The
obtained samples were then stored at 4 ◦C for further experiments.
2.16. Nucleotide Sequence Accession Numbers
The annotated nucleotide sequences of the phage genomes were submitted to sequence databases
under the following accession numbers: fEg-Aba01 (MT344103), fLi-Aba02 (MT344104) and fLi-Aba03
(MT344105). The raw sequence read data of A. baumannii strains #5707, #5907, #5920 and #6597 was
deposited to NCBI sequence read archive under bioproject PRJNA625727, and received the accession
numbers SRX8124491, SRX8124492, SRX8124492, and SRX8124494, respectively.
3. Results
3.1. Phage Isolation and Phenotypic Characterization
Enrichments were carried out in pools of ten clinical A. baumannii strains each and the
obtained sterile-filtered pool-lysates were then tested for phages using each clinical A. baumannii
strain individually as indicator bacteria in the soft agar plates. Phage activity was detected only
against one of the strains, the A. baumannii strain #6597 (Table S1). After several rounds of plaque
purification from different lysates, three phages named vB_AbaS_fEg-Aba01, vB_AbaS_fLi-Aba02
and vB_AbaS_fLi-Aba03 (hereafter referred to as fEg-Aba01, fLi-Aba02 and fLi-Aba03, respectively)
were obtained.
The three phages showed very similar plaque morphologies and formed round slightly turbid
1–1.5 mm diameter plaques with haloes on A. baumannii #6597 (Figure S1). Transmission electron
microscopy revealed that all the phages resemble morphologically Siphoviridae (Figure 1). The physical
dimensions of the phages are listed in Table 1. The phages possess icosahedral capsids (58–63 nm
in diameter) to which a long, flexible and non-contractile tail (136–156 nm in length and 8–9 nm in
diameter) was attached (Table 1).
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Table 1. Phage particle and genome overview. Phage dimensions were measured by TEM and represent
mean values for at least 10 measured phage particles.
Bacteriophage fEg-Aba01 fLi-Aba02 fLi-Aba03
Capsid size, nm 58.4 ± 4 63 ± 2 58.6 ± 5
Tail length, nm 156 ± 9 136 ± 1.8 142 ± 0.8
Tail width, nm 10.8 ± 0.3 9 ± 0.2 8.5 ± 0.9
Genome size, bp 33,779 35,053 34,931
GC content (%) 40.1 40.2 40.1
n genes 52 53 54
n tRNAs 1 1 1
Adsorption is the first decisive step of phage infection of host bacteria. The adsorption curves of
the phages showed that the phages fEg-Aba01, fLi-Aba02 and fLi-Aba03 adsorbed extremely rapidly
onto A. baumannii #6597 bacteria. Within 1 min >98% of the free phage particles had already adsorbed
to the host bacteria, and at 5 min nearly 100% were adsorbed (Figure 2).
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The phage titer in he control supernatant was set to 100% and the residual titers at different time points
were related to that. Each assay was perform d in duplicate and repeated for 3 times. Note the
standard deviation bars are mostly hidden behind the symbols.
The host ranges of phages fEg-Abo01, fLi-Aba02 and fLi-Aba03 were tested with 91 strains
representing 14 species (Table S1). The phages infected only the original A. baumannii host strain #6597,
and in addition, a recent MDR A. baumannii patient isolate, strain #6898 (Table S1).
3.2. Phage Genomic Characterization, Annotation and Comparison to Other Phages
Each de novo assembly of the Illumina sequencing reads of the phages resulted in >100 contigs.
While for each phage, one contig, 33–35 kb in size, had very high read coverage, the read coverage of
the other contigs was low. In addition, as the BLASTN searches with the low-coverage contigs revealed
that they represented A. bauman ii genomic equences, it i very likely that they represent host bacterial
DNA sequen es either as contaminants in the phag DNA samples or through tra sduction. Thus the
high-coverage contigs represented the phage genomic sequences, and the low-coverage contigs were
excluded from further study.
The three phage sequences were highly similar (>99% identical) with each other, however, they
showed no similarity to any phage genomes deposited in the sequence databases. The restriction
digestion patterns of the three phages were almost identical (two shown in Figure S3). Comparison of
the sequence-based and experimental restriction digestion patterns allowed rough mapping of the
physical ends of the phage genomes, however, the PhageTerm analysis allowed exact identification
of the ends, and it revealed that the three phages each contained 10 nt long 3’-cohesive ends with
identi al sequences: 5’-CGCCCCCCAT-3’ (Figure S4). o confirm the presence of the cohesive ends,
EcoRI digested phage DNA was analyzed in agarose gel after heat treatment at 80 ◦C and either cooled
rapidly on ice or allowed to cool slowly to RT. The cohesive ends in the latter case annealed to each
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other and produced a visible larger band in the gel (Figure 3B). Based on these results the genome
sequences were rearranged to represent the linear genomes in the phage particles and to locate the
majority of the predicted genes to the forward direction. Finally, the experimental restriction enzyme
digestions of the phage DNA were in perfect match with in silico restriction digestion fragment sizes
(Figure 3A) that are as follows:
• EcoRI (10231, 8997, 8427, 2482, 1196 left end, 1150 right end, 604, 522, 170 bp)
• HincII (9559, 8170, 5179, 2713, 2546, 2074, 1228 right end, 767, 711, 496, 219, 117 left end)
• NsiI (9006, 8804, 6595, 3916, 2482 right end, 2104, left end, 872)
• PstI (11219, 5337, 4003, 3313, 2405, 2240, 1474 left end, 1295 right end, 912, 699, 444, 438)
• SaII (22168 right end, 11611 left end)
• ScaI (23619 right end, 10160 left end)
• SexAI (22976 right end, 10803 left end)
• SpeI (13517 left end, 7659, 5298, 2926, 2907, 1185, 287 right end)
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Figure 3. Agarose-gel-electrophoresis analysis of restriction enzyme digested fEgAba01 DNA. Panel
(A) fEg-Aba01 genomic DNA digested with EcoRI (lane 2), HincII (lane 3), NsiI (lane 4), PstI (lane 5),
SaII (lane 6), ScaI (lane 7), SexAI (lane 8), and SpeI (lane 9). Lane 1, undigested DNA. Lane M, 1-Kb
DNA ladder. Pan l (B), confirmation of the cohesive ends. Lanes: 1, undig d phage DNA; lane 2,
EcoRI-digested DNA, the red arrow indicates the joint fragment; lane 3, EcoRI-digested phage DNA,
heated after digestion at 80 ◦C for 15 min, followed by rapid cooling to room temperature (RT). The red
arrows indicate the left and right end EcoRI fragments. The black arrows indicate the 2482 bp fragment.
Annotation of the seque ces showed that fEg-Aba01 consisted of 52, fLi-Aba02, of 53, and
fLi-Aba03, of 54, pr dicted genes (Table 1 and Table S3). Seven of the genes in each were encoded
in the reverse strand. The GC contents of the phages were similar, 40.1–40.2% (Table 1) that is very
close to the GC content of A. baumannii host, ca. 39% [60]. The overall organization of the genome of
fEg-Aba01 is presented in Figure 4.
While no similar phages were found from nucleotide sequence databases, a 99% identical 35 kb
genomic island (GI5) annotated as a prophage is present in the A. baumannii strain AbPK1 genome
(GenBank accession number CP024576.1). The AbPK1 strain was isolated as the causative agent of
virulent epidemic p eumonia that kil ed hundreds of sheep on a farm i Pakistan [60]. In addition, the
predicted CP14 prophage of three other A. baumannii strains (AB042, AB043 and ATCC17978, acc. no
CP019034, CP043910, CP018664, respectively) showed 80% identity to fEg-Aba01 [61].
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labelled with predicted functions (Genes encoding structural proteins, brown; lysogen functions, purple;
nucleic acid enzymes, blue; hypothetical proteins, grey; tRNA gene and the 3’-cohesive end, red; lysis
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Geneious 10.2.6 (www.geneious.com). HP, hypothetical protein; pr, protein.
The predicted functions of the phage gene products, based on database searches, are shown in
Table S3. A putative function could be assigned to ca. 30 gene products leaving 22 annotated as
hypothetical proteins. Five functional groups were identified:
1. The lysogen decision gene clusters of the three phages were identified and the gene products
annotated based on similarity searches (Table 2). The integrase (Gp25 in fEg-Aba01; Gp27 in
fLi-Aba02 and fLi-Aba03) is 100% identical in all three phages. It is the site-specific recombinase
that by catalyzing recombination between the two DNA molecules results in either integration or
excision of the prophage into and from the host chromosome [62]. The arginine (Gp27c; Gp29c) and
the CI-like (Gp32c; Gp34c) repressors account for the establishment of lysogeny and the immunity
of lysogens to superinfection. The production of CI represses the Cro (Gp33; Gp35) synthesis.
The excisionase (Gp26c; Gp28c) binds to the integrase and enables it to reverse the integration
process and liberate the prophage. The Xre family transcriptional regulator (Gp30c; Gp32c)
and another repressor (Gp35; Gp37) may also be involved in the regulation of lysogeny/lysis
decision. Traditionally, the lysogeny/lysis decision is regulated by the competition between CI
repressor and Cro proteins for the occupancy of the operator (OR) region. The Cro protein binds
to the OR and OL promotors and turns off the transcription of the CI repressor gene and thus
allows transcription and translation of the lytic cycle and other late genes [63]. Some integrases
are associated in the integration and excision of phage genomes, whilst others are essential for
the maintenance of plasmid copy number or elimination of chromosomal dimers [64–66]. A
phylogenetic tree of Acinetobacter site-specific integrase sequences was constructed (Figure 5).
The results demonstrate that Gp25 integrase clusters among the bacteriophage Hp1-like tyrosine
integrases in the XerC superfamily. The ADP-ribosyltransferase (Gp28c; Gp30c) and the antitoxin
(Gp29c; Gp31c) may be a toxin-antitoxin pair stabilizing the lysogen [67]. The hypothetical
protein (Gp31c; Gp33c) is similar to a A. baumannii protein that shares a fold with a cell division
regulator protein of Streptococcus pneumonia GbsP [68] and may interact with the bacterial cell
wall synthesis.
2. The DNA synthesis, regulation and replication gene products include the Xre family transcriptional
regulator (Gp30c; Gp32c), the DNA helicase (Gp36; Gp38) that unwinds the DNA to create
template for DNA replication [69], and another repressor (Gp35; Gp37) likely involved in gene
regulation. The putative HNH endonucleases (Gp38, Gp45 and Gp51; Gp40, Gp47 and Gp53)
may play a variety of roles in replication, recombination, and repair pathways [70]. Finally, the
antiterminator protein (Gp41; Gp43) renders RNA polymerase resistant to termination signals [71].
3. The DNA packaging into the phage head is carried out by the terminase complex containing
the small and large terminase subunits (Gp01 and Gp03, respectively). It recognizes the cos site,
introduces there the nicks to generate the cohesive ends to the genome and separates the cohesive
ends in a reaction requiring ATP hydrolysis [72]. The terminase and the phage portal proteins
(Gp04, Gp08 and Gp11) are believed to be the initiators of the head assembly. The NinB homolog
(Gp48; Gp50) may be associated in recombination.
4. The phage structural proteins are encoded by the genes encoded in the left half of the genome
(Figure 4), and include Gp05 and Gp06 that are annotated as capsid and major capsid proteins,
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respectively, that initiate formation of the procapsid [73], Gp09 is the putative phage head-tail
adaptor, Gp16, the tail length tape-measure protein, and Gp12, the major tail protein. Gp8 and
Gp10 are also structural peorteins, and Gp18 (Gp20 in fLi-Aba02 and fLi-Aba03) is also predicted
to be a tail component (Table S3). Gp13 is a putative tail assembly chaperone. The predicted tail
length based on the tape measure protein of 1195 amino acid residues, 1.5 Å per residue [74],
would be ca 180 nm, that is 20–30 nm longer than the measured tail lengths (Table 1). Perhaps the
tape measure protein extends to the tip of the bulky tail baseplate omitted from the measures.
5. The host lysis protein holin is predicted to be Gp21 (Gp23 in fLi-Aba02 and fLi-Aba03), and Gp22
(Gp24 in fLi-Aba02 and fLi-Aba03), the lysozyme, involved in the bacterial lysis and release of the
phage progeny [75]. The predicted peptidoglycan hydrolase (Gp19 in fLi-Aba02 and fLi-Aba03)
encoding gene is not present in fEg-Aba01, actually, it is deleted and the g18 in fEg-Aba01 is
a fusion product containing 5’-end of gene g18 and 3’-end of gene g20 of fLi-Aba02 (Table S3).
The acetylxylan esterase and lectin-like proteins (Gp19;Gp21 and Gp20;Gp21, respectively) are
both carbohydrate-associated proteins and might have a function in degrading the bacterial
capsule polysaccharides.
Table 2. The lysogen decision gene cluster in phages fEg-Aba01, fLi-Aba02, and fLi-Aba-03.
Gene Location Predicted Function Amino Acids
g25fEg-Aba01 20438-21397
Integrase
319
g27fLi-Aba02 22436-21477 319
g27fLi-Aba03 22436-21477 319
g26cfEg-Aba01 21614-21363
Excisionase
83
g28cfLi-Aba02 22653-22402 83
g28cfLi-Aba03 22653-22402 83
g27cfEg-Aba01 22353-21667
Arginine repressor
228
g29cfLi-Aba02 23392-22706 228
g29cfLi-Aba03 23392-22706 228
g28cfEg-Aba01 23182-22595
ADP-ribosyltransferase
195
g30cfLi-Aba02 24429-23392 345
g30cfLi-Aba03 24267-23392 291
g29cfEg-Aba01 23494-23258
Antitoxin
78
g31cfLi-Aba02 24741-24505 78
g31cfLi-Aba03 24579-24343 78
g30cfEg-Aba01 24113-23478 Xre family
transcriptional regulator
211
g32cfLi-Aba02 25360-24725 211
g32cfLi-Aba03 25198-24563 211
g31cfEg-Aba01 24406-24116
Hypothetical protein
96
g33cfLi-Aba02 25653-25363 96
g33cfLi-Aba03 25491-25201 96
g32cfEg-Aba01 25397-24657
Repressor protein CI
246
g34cfLi-Aba02 26596-25904 230
g34cfLi-Aba03 26434-25742 230
g33fEg-Aba01 25663-25421
Cro repressor
80
g35fLi-Aba02 26910-26725 61
g35fLi-Aba03 26748-26521 75
Multiple genome alignment of the three phages and the prophage sequences of the A. baumannii
strain AbPK1 (from CP024576.1) and those of strains #5707 and #5920 revealed several regions
of differences (RoD) with overview in Table 3 and detailed illustration in Figure S5. The
alignment demonstrates that all the genomes resemble closely each other (Figure S5A) and that
local deletions/insertions/substitutions have taken place (Figure S5B). The RoD-02 deletion of 832 bp
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in fEg-Aba01 deleted the predicted peptidoglycan hydrolase gene (g19 in fLi-Aba02) and generated
the fusion gene g18 in fEg-Aba01. Visual inspection of the RoDs (Figure S5B) also demonstrated that
single nucleotide substitutions were mainly present in the AbPK1 prophage sequence (RoD-03, RoD-06
and RoD-08) suggesting that it is more distantly related to the others, this is also evident from the
whole-genome phylogenetic tree (Figure S5A) where fEg-Aba01 is an outgroup and the other five
sequences cluster together. Remarkably, the fLi-Aba02 was almost identical with the prophages of
strains #5707 and #5920 while fLi-Aba03 differed from those only in RoD-06. The fEg-Aba01 genome
differed from the others based on the deletions in RoD-01, RoD-02, RoD-05 and RoD-05 that all caused
severe rearrangements.Viruses 2020, 5, x FOR PEER REVIEW 12 of 20 
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Figure 5. The phylogenetic tree of fEgAb01 integrase with different site-specific Acinetobacter
integrases and rooted with the Haemophilus influenza and Pseudomonas aeruginosa integrases. The tree
was constructed using the MEGA X neighbor-joining statistical tree analysis method with bootstrapping
set to 1000 tree branches are proportional to branch lengths. The branch labels rep esent bootstrap
values. Th integrase of fEg.Aba01 is highlighted in yellow.
Table 3. The regions of differences (RoD) between the nucleotide sequences of the three temperate
Acinetobacter phages and the prophage loci of A. baumannii strains AbPK1, #5707 and #5920. See Figure
S5 for det ils.
Region of
Difference Location in fEg-Aba01 Description
RoD-01 18065..18066
207 bp in-frame deletion in g20 of
fEg-Aba01 that causes a 69 amino acid
truncation of Gp20.
RoD-02 13550..13551
A 832 bp deletion in fEg-Aba01 that
generates a fusion of genes corresponding
to g18 and g20 of phages fLi-Aba02 and
fLi-Aba03. The deletion includes the gene
g19 of the latter.
RoD-03 6915..6925
Five nucleotid substitutions in a str tch of
11 bp within g10 of AbPK1 prophage
causing one (Arg-to-Lys) neutral
substitution.
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Table 3. Cont.
Region of
Difference Location in fEg-Aba01 Description
RoD-04 32618 A silent one nucleotide substitution in g50of fEg-Aba01
RoD-05 32453..32454
A 67 bp deletion in g50 of fEg-Aba01
causing a frame shift mutation and
truncating the 3’-end of g48
RoD-06 24177 A one bp substitution in gene g32c causing aSer to Phe substitution in the AbPK1 protein
RoD-07 22613..22772
A stretch of three variants of 27 bp
repetitions (6–13 repetitions) in the 3’end of
gene g28c. Also out of frame deletions in
the fEg-Aba01 gene causing frame shift and
3’-end truncation. Identical full length
region is present in fLi-Aba02, and the
#5707 and #5920 prophages
RoD-08 21103 A silent one bp substitution in the integrasegene g27 of AbPK1 prophage
3.3. Prophage Lysogenic Characteristics
This suggested that the origin of the phages could be a prophage in any of the twenty clinical
A. baumannii strains used in the enrichment experiment. To this end we designed two phage-specific
primer pairs to detect the presence of the putative prophages by PCR and used the isolated DNA from
each of the twenty clinical A. baumannii strains as template. Phage genome DNA was used as a positive
control. Three strains (#5707, #5907 and #5920) gave strong positive PCR results with both primer pairs
(Table S4).
To confirm these results the genomic DNA of these strains together with strain #6597 were
sequenced and the obtained raw read data was used in de novo assembly, and the reads were also
mapped directly to the three phage genomes used as references. These results confirmed that the
strains #5707 and #5920, but not #5907, carried the whole prophage (Figure S6). Based on the whole
genome sequence data the MLST, capsular (K) and lipo-oligosaccharide (LOS) types were determined
for the strains (Table 4). These data shows that the prophage-positive strains #5707 and #5920 are very
similar as they both have the same MLST, and LOS and capsule types. The other two strains differ
from the two and from each other. BLASTN alignment of the sequence data of the strains against the
prophage locus of AbPK1 (Figure S5) shows that strain #5907 carries a truncated prophage genome
while the prophage sequences are completely absent from strain #6597. The truncated prophage
corresponds to AbPK1 nucleotides from 2546100 to 2560500 (acc. no. CP024576.1), explaining the
positive 700 bp PCR result for this strain (Table S4). Interestingly though, the location of the truncated
prophage sequences of #5907 were not the same where the prophage is located in AbPK1.
Table 4. Whole genome sequence data based overview of A. baumannii strains.
Strain MLST LOS-Type K-Type Prophage
#5707 1114, 1841 OCL1 KL25 Yes
#5907 1806, 208 OCL1 KL2 Partial
#5920 1114, 1841 OCL1 KL25 Yes
#6597 1816, 195 OCL1 KL3 No
AbPK1 452 OCL1 KL3 Yes
In a population of lysogenic bacteria a few at times enter the lytic cycle and phages are released in
small quantities into the growth medium. To detect this experimentally the clinical strains #5707 and
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#5920 were grown in liquid medium to stationary phase. The presence of strain #6597 specific phages
was detected from the culture supernatants of both lysogenic strains confirming that the strains very
likely were the origin of the phages (data not shown).
The presence of the prophage in the genomic sequences of the three A. baumannii strains, i.e.,
of AbPK1 (from CP024576.1) and of strains #5707 and #5920 (this work) allowed the identification
of the attachment site (attB) in the bacterial genome as it is duplicated upon the integration of the
phage genome. Thus, the identical attachment site sequences are present in both the phage and the
host genomes. The phage-encoded integrase enzyme, with the aid of a special host protein, catalyzes
site-specific recombination, i.e., the physical exchange of viral and bacterial DNA strands Figure 6). The
circular phage DNA is thereby integrated into the host genome as a linear prophage. Comparison of
the phage sequences to the genome sequence of A. baumannii AbPK1 revealed that the attachment site
sequence is a 22-bp sequence 5’-AAAAAGCGCTCAATCTAGAGCG-3’, located in the phage genome
upstream of the predicted tyrosine family integrase encoding gene (Figure 4). This sequence was
described as target site duplication (TSD) in the A. baumannii AbPK1 genome [60]. Identical attB sites
were also identified from the lysogenic strains #5707 and #5920.
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phage int gration and excision.
To provide experim ntal evid nce of the temp rate nature of the p ages, phage fEg-Aba01 resistant
derivatives, i.e., potential lysogens, of A. baumannii strain #6597 were isolated from fEg-Aba01 –infected
bacterial lawns. PCR using phage-specific and att-site flanking primers (Table S2, Figure S2) was used
to detect the presence of prophage in the lysogen candidates (Table S5). All the candidates proved to
be positive confirming the temperate nature of the phage.
4. Discussion
We present here our findings suggesting that the three isolated A. baumannii siphophages were
very likely prophages induced spontaneously during the culture of the lysogenic strains #5707 and
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#5920. As there is only limited information of the biological properties of temperate A. baumannii
phages we present here a detailed characterization of the phages, and show experimentally that the
prophages in #5707 and #5920 can be induced, and on the other hand that the phages can lysogenize a
non-lysogenic strain. This indicated that the phages are fully functional. It is worth noting that these
two lysogenic strains, in addition to sharing their MLST and capsule types, carry almost identical
prophages, therefore either of them or both could be the original host of the isolated temperate phages.
Comparison of the phage and prophage sequences demonstrated that they were almost 100% identical
differing only by a few occurrences of substitutions/deletions/insertions (Figure S5). It is, therefore,
very likely that some of the mutations took place during the laboratory propagation of the phages as
none of the three were fully identical to the prophage sequences in strains #5707 and #5920 (Figure
S5). Based on the whole-genome VICTOR phylogenetic prediction (Figure S5A) it is apparent that
fLi-Aba02 is closest to the prophages of #5707 and #5920, followed by fLi-Aba03, leaving fEg-Aba01
as most distant. Of special interest is the deletion/gene fusion in fEg-Aba01 (RoD-02, Table 3), that
potentially could affect the phage biology. The deleted sequence carries the gene predicted to encode a
peptidoglycan hydrolase (g19 of fLi-Aba02 and fLi-Aba03) that might be involved in the lysis of the
bacterial cell and the release of the phage progeny. This deletion seems to be well tolerated as we
observed no gross differences between the three phages. The same applied apparently to the other
major differences in fEg-Aba01 affected genes g48 and g28c (RoD-05 and RoD-07), truncating both from
the 3’-end. This short-term evolution of the phages allows identification of non-essential regions of the
phage genomes.
When isolating the phages, among the 20 clinical A. baumannii strains was one, #6597 that was
sensitive to the phages and made their detection possible. Interestingly, among the 53 Acinetobacter
strains representing 7 species in addition to A. baumannii, only two A. baumannii strains were sensitive
to the phages. This narrow host range could be due to several different reasons: (i) the phage receptor
structures (LOS, capsule or outer membrane proteins) of the strains are different, (ii) the strains might
be lysogens similar to #5707 and #5920, (iii) other resident prophages may encode an infection exclusion
system or (iv) the presence of phage-specific spacers in the CRISPR/Cas locus [76]. The fact that all
the strains shared the LOS type, and that the phage-sensitive strain #6597 represents capsule type
KL3 (Table 4) makes it likely that the phages are KL3 specific. There is a discrepancy; the temperate
phages infect only the KL3 strain but reside as prophages in KL25 strain. The structures of the KL3
and KL25 capsule polysaccharides are completely different [77,78], thus, one can ask the question
how they entered in the first place into the KL25 strain. One can entertain two scenarios. First, if the
phage receptor is indeed KL3, then the prophage should have entered the KL25 lineage before they
have taken up the KL25 capsule gene cluster, or alternatively, the prophage has been transduced by
a KL25 specific phage, or second, the phage receptor is not the KL3 capsule but an outer membrane
protein. The fact that the phage plaque is surrounded by a halo, indicates that a diffusible enzymatic
activity, likely associated with the phage tail, is degrading the capsular polysaccharide around the
plaque, indirectly indicating that the KL3 capsule is specifically recognized by the phage. This question
remains to be addressed in future.
The phages were morphologically typical siphoviruses with heads of about 60 nm in diameter,
and flexible non-contractile tails of 140–150 nm in length, the genomes 33.8–35.0 kb in size encoding
52–54 predicted genes. We identified the attP sequence of the phage, and demonstrated experimentally
that the phage has cohesive termini that the PhageTerm tool predicted to be 10 nt long (Figure S3).
The adsorption curves of the phages (Figure 2) demonstrated that the phages adsorb to the bacteria
extremely rapidly and efficiently with >95% of phages adsorbed already at the first time point of 1 min.
Several genomic data screening studies have been carried out to identify prophages that indeed
turn out to be very abundant in A. baumannii genomes [33,61,79]. It is apparent that many of the
identified prophages may also be involved in horizontal gene transfer and may carry genes encoding
antibiotic resistance or virulence factors [79], however, this was not the case with the prophages
identified in this work. Of note, the gene claimed to encode sialic acid acetyltransferase 3 in GI5 of
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AbPK1 [60] was here based on HHpred search annotated as acetylxylan esterase like protein (Gp19),
thus a hydrolase, so it very likely may have a function in capsule degradation. While spontaneous
induction of the prophages as described in the present study has not been reported earlier, prophage
induction using mitomycin C has been reported [33,79]. Similarly, the phage vB_AbaS_TRS1, a 40.7 kb
siphovirus, was induced by mitomycin C treatment from the A. baumannii strain A118 culture [80],
however, it did not show any similarity to fEg-Aba01 and the other phages described here. On the
other hand, based on the >99% identity of prophage GI5 of AbPK1 is very likely that it would behave
identically to the spontaneously inducible phages described in this work.
As temperate phages are not considered suitable for phage therapy, non-lysogenic derivatives of
the isolated phages could be constructed in future by targeted deletion of the lysogen decision gene
cluster, similar to the strategy used in the recent Mycobacterium abscessus phage treatment case [81],
provided that the selected phages do not carry any harmful genes. This could be worthwhile if there are
difficulties in isolating Acinetobacter phages that we have experienced in Finland, and as the adsorption
curves of the phages showed extraordinary adsorption rates suggesting also high efficiency in killing
the target bacteria [82].
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/12/6/604/s1,
Figure S1: plaque morphology of fEg-Aba01. Figure S2: schematic representation of the primers used to confirm
the presence of the prophage in bacterial genomes. B, B’, P and P’ represent the bacterial and phage attachment
site sequences. Figure S3: restriction digestion analysis of phages fEg-Aba01 and fLi-Aba02 digested with 8
different enzymes demonstrating the >99% sequence identity of the phages. Figure S4: PhageTerm analysis of the
fEg-Aba01 sequence read data demonstrating the presence of HK97 type 10 nt long 3’ cohesive ends. Figure S5:
comparison of the of the nucleotide sequences of the three temperate Acinetobacter phages and the prophage loci
of A. baumannii strains AbPK1, #5707 and #5920. Figure S6: BLASTN alignment of the prophage of A. baumannii
strain AbPK1 against the whole genome de novo assembly contigs of strains #5707, #5907, #5920, and #6597. The
ABPK1 sequence contained short prophage-flanking sequences up- and down-stream of the prophage. While
#6597 completely lacks the prophage, it is completely present in #5707 and #5920, and partially in #5907. Table
S1: bacterial strains used in the work. Table S2: oligonucleotide primers used for PCR in the work. Table S3:
annotations and comparisons of the phage and prophage gene products. Table S4: detection of prophage specific
sequences by PCR in the clinical strains used for phage enrichment using prophage-specific primer pairs. Table S5:
detection of prophage sequences in lysogens by PCR.
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